Medically Assisted Dying: Worries Grow in Canada
Worries Grow About Medically Assisted Dying in Canada The Lancet Sept 9 2022
Posts in category Addiction, Depression, Psychosis, Schizophrenia
Help for often-hidden illnesses
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaBusinessDigital HealthEpidemics & PandemicsHealthcare PoliticsHealthcare Privatization: A Global Business Campaign
Medicare’s Public-Private Virtualization (The Logic, Nov 27 2021)
For Telus CEO Darren Entwistle, virtual health is personal – The Logic
The Lancet: Canada’s prison mental health crisis
Lancet Psychiatry July 2019 Prison Mental Health
Positive Psychology Goes Global
Lancet June 1 2019 Global wellness survey
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaBusinessDrug PoliticsHealthcare Politics
Psychedelic therapies?
Lancet May 19 2019 Psychedelic therapy
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaDrug PoliticsHealthcare Politics
Canada’s expanding cannabis market sparks worries
Lancet Jan 12 2019 Canada’s expanding cannabis market
Addiction, Depression, Psychosis, SchizophreniaDiseases of NeglectDrug PoliticsHealthcare PoliticsMedically-Induced Opioid Addiction
Opioid Advertising Worries Continue
CMAJ June 11 2018 Opioid Advertising Worries Remain
New Drugs for Psychosis & Schizophrenia
The Lancet May 5 2018 FDA Pimavanserin review
Addiction, Depression, Psychosis, SchizophreniaCanadian Science PolicyDrug PoliticsHealthcare Politics
Urgent call for cannabis health research solutions
With the deadline for legalization of nonmedical marijuana approaching, scientists studying the health impacts of cannabis are calling on the federal government to implement a comprehensive research program. “Considerably more …